Cravath Swaine & Moore represented Amgen. The Federal Trade Commission (“FTC”) filed suit in Illinois federal court in May 2023 seeking a temporary restraining order and a preliminary...
You must be a Standard 1 Year member to access this content.
df-mp Dörries Frank-Molnia & Pohlman and Bardehle Pagenberg advised Amgen, while Zwicker Schnappauf & Partne and Carpmaels & Ransford advised Sanofi. As part of their global...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Amgen, and Shearman & Sterling advised the underwriters. Amgen Inc. priced an offering of $24.0 billion aggregate principal amount of senior notes,...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Amgen Inc on the deal. Amgen Inc (NASDAQ:AMGN) announced its acquisition of Rodeo Therapeutics. Amgen is one of...
You must be a Standard 1 Year member to access this content.
